A biotech company dedicated to the discovery and development of protein therapeutics using its proprietary alphabody™ technology. Alphabodies are robust and versatile protein scaffolds, unrelated to immunoglobulins, and inspired by naturally occurring motives. Complix’s proprietary Cell Penetrating Alphabody (CPAB) technology allows it to access a broad range of intracellular disease related targets that are considered “intractable” by currently available drug formats, such as antibodies and small molecules.
View Top Employees from Complix N.V.Website | http://www.complix.com |
Revenue | $30 million |
Employees | 15 (15 on RocketReach) |
Founded | 2008 |
Address | 94 Technologiepark, Gent Zwijnaarde, Flanders 9052, BE |
Phone | (329) 261-6940 |
Fax | (329) 261-6950 |
Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Business Services General, Biopharmaceuticals, Business Services, Science and Engineering, Drug Discovery, Health Care, Therapeutics |
Web Rank | 28 Million |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies |
Looking for a particular Complix N.V. employee's phone or email?
The Complix N.V. annual revenue was $30 million in 2024.
Stefan Loverix is the Head Discovery of Complix N.V..
15 people are employed at Complix N.V..
Complix N.V. is based in Gent Zwijnaarde, Flanders.
The NAICS codes for Complix N.V. are [54171, 54, 5417, 541714, 541].
The SIC codes for Complix N.V. are [873, 87].